Physician
Ophthalmology
Dr. Charles Q. Huang, MD
|
|
Give Review
Doctor Charles Q. Huang, MD works in the field of Ophthalmology. He went to medical school at University of California Davis School of Medicine. University of California Davis School of Medicine is ranked 43/19 in Research/PrimaryCare. He received 1 awards: "Meaningful Use Stage 1 Certification". Charles Q. Huang, MD is a published doctor as well. He has 22 publications published. The latest was: NF-?B1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1.
Publications
- NF-?B1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1.
- Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamin...
- Humphrey Matrix perimetry in optic nerve and chiasmal disorders: comparison with Humphrey SITA standard 24-2.
- Sensitivity and specificity of the Humphrey Matrix to detect homonymous hemianopias.
- Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists.
- Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a seri...
- Pretransplantation soluble adhesion molecule expression predicts outcome after living donor renal transplantation.
- Aniridia and Brachmann-de Lange syndrome: a review of Ocular surface and anterior segment findings.
- Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists.
- Synthesis of 1-methyl-3-phenylpyrazolo[4,3-b]pyridines via a methylation of 4-phthalimino-3-phenylpyrazoles and optimization toward highly potent corticotropin-releasi...
- Synthesis of 3-phenylpyrazolo[4,3-b]pyridines via a convenient synthesis of 4-amino-3-arylpyrazoles and SAR of corticotropin-releasing factor receptor type-1 antagonists.
- 6,7-dihydroxyisoquinoline-3-carboxylic acids are potent inhibitors on the binding of insulin-like growth factor (IGF) to IGF-binding proteins: optimization of the 1-po...
- Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists.
- Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptor.
- Optimization of 3-phenylpyrazolo[1,5-a]pyrimidines as potent corticotropin-releasing factor-1 antagonists with adequate lipophilicity and water solubility.
- Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonists.
- 1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists.
- Uracils as potent antagonists of the human gonadotropin-releasing hormone receptor without atropisomers.
- Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonists.
- Zwitterionic uracil derivatives as potent GnRH receptor antagonists with improved pharmaceutical properties.
- Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activity.
Schools
University of California At Irvine California College of Medicine amp Surgery
Procedures Preformed
- Cataract Removal Surgery
- Excision of Chalazion
- Eyelid Surgery
- Pterygium Excision
Conditions Treated
- Blepharitis
- Cataract
- Chalazion
- Chorioretinal Scars
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of California Davis -
University of California Davis School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Wei Jiang, MD |
|
|
Dr. Daniel S. Glantz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Elia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny E. Hong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd A. Auker, MD
This Doctor is OpenDoctor Recommended.
|